YOUNG DAVID (Chief Executive Officer) purchased 12.1% of their position (2.07K shares) of PROCESSA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $4.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/16/2026ACC: 0000897069-26-001414
DirectorOfficer· Chief Executive Officer
Since Oct 2020
+2.07K
Net shares
Net buyer
$4.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.07K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.07K
Price / share
$2.22
Trade value
$4.59K
% of position
12.1%
6/15/2026
17.13K→19.20K
Total
Net shares
+2.07K
Net value
$4.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | P · Purchase | +2.07K | $2.22 | $4.59K | 12.1% | 17.13K | 19.20K |
| Total | +2.07K | $4.59K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned432.00
Common Stock
IndirectShares owned1.01K
Common Stock
IndirectShares owned1.24K
Total
2.68K indirect2.68K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 432.00 | Indirect |
| Common Stock | 1.01K | Indirect |
| Common Stock | 1.24K | Indirect |
| Total | 2.68K | 2.68K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported